Upload
truongtuyen
View
247
Download
3
Embed Size (px)
Citation preview
aca
Copyright © 2012 International Market Analysis Research & Consulting (IMARC). All Rights Reserved
Imarc www.imarcgroup.com
Country Covered : Global
Global Pharmaceutical Market Report & Forecast:
(2012-2017)
October 2012
IMARC
About the Report
The global pharmaceutical market is expected to grow at a CAGR of 5% during 2011-2017, exceeding
sales worth US$ 1.1 Trillion by 2017. This market, however, is expected to undergo a number of
transitions which would impact the course of its growth. These transitions include a shift of growth from
the developed to the emerging markets, an increasing focus on biopharmaceuticals compared to small
molecule drugs and an increasing preference for generics compared to their branded versions. As a
result of these transformations; the need for a user friendly, robust and comprehensive pharmaceutical
market intelligence has become imperative for investors, researchers, consultants, marketing strategists,
and all those who are planning to foray into the pharmaceutical market in some form or the other.
IMARC Group, one of the world’s leading research and advisory firms, introduces a new and
revolutionary way to understand and evaluate the global pharmaceutical market with its Microsoft Excel
based report entitled “Global Pharmaceutical Market Report & Forecast: 2012-2017”. This report
provides an analytical and statistical insight into the global pharmaceutical market. The study, which has
been undertaken using desk based as well as primary market research has analyzed the following
aspects of the global pharmaceutical market.
What We Have Achieved in This Report?
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America & Caribbean and Middle
East & Africa
Countries Covered in Each Region
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands, Poland, Greece,
Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania, Denmark, Czech Republic, Finland,
Ireland, Norway, Slovakia, Bulgaria, Croatia, Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand, Philippines,
Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico, Colombia, Chile,
Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab Emirates
Lebanon, Tunisia, Jordan and Kuwait
IMARC
Focus of the Analysis:
Historical sales performance (2007-2011) for each country
Historical sales performance (2007-2011) for each region
Sales forecast (2012-2017) for each country
Sales forecast (2012-2017) for each region
Sales performance of key manufacturers for each country (2007-2011)
Sales performance of key therapeutic areas for each country (2007-2011)
Country wise sales breakup for each region (2007-2011)
Country wise sales breakup forecast for each region (2012-2017)
Key Questions Answered;
What was the historical performance of the global pharmaceutical market?
Which are the key regions and countries in the global pharmaceutical market?
Which are the largest pharmaceutical markets in the world?
Which are the fastest growing pharmaceutical markets in the world?
Which markets are expected to witness the slowest growth in the coming years?
Which countries represent the key markets for each region?
What has been the performance of various therapeutic classes in each country?
Who are the top pharmaceutical manufacturers in each country?
What are the market shares of the top pharmaceutical manufacturers in each country?
Why You should Buy This Report?
To gain a comprehensive understanding on the historical, current and future pharmaceutical
market trends across 70 countries in 6 regions.
To identify potential regions, countries, therapeutic areas, partners and competitors for market
entry and expansion plans.
As a tool for developing investment strategies by identifying the biggest winners and losers
across various regions and countries.
To ensure a successful M&A and partnership strategy by identifying therapeutic areas and
companies with the most promising outlook.
IMARC
Table of Contents Analysis by Country Global Figure 1: Global: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Global: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Global: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Global: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Global: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Global: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Algeria Figure 1: Algeria: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Algeria: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Algeria: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Algeria: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Algeria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Algeria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Argentina Figure 1: Argentina: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Argentina: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Argentina: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Argentina: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Algeria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Argentina: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Australia Figure 1: Australia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Australia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Australia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Australia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Australia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Australia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Austria Figure 1: Austria: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Austria: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Austria: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Austria: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Austria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Austria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Bangladesh Figure 1: Bangladesh: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Bangladesh: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Bangladesh: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Bangladesh: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Bangladesh: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Bangladesh: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Belgium Figure 1: Belgium: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Belgium: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Belgium: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Belgium: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Belgium: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Belgium: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Brazil Figure 1: Brazil: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Brazil: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Brazil: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Brazil: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Brazil: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011
IMARC
Figure 6: Brazil: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Bulgaria Figure 1: Bulgaria: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Bulgaria: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Bulgaria: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Bulgaria: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Bulgaria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Bulgaria: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Canada Figure 1: Canada: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Canada: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Canada: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Canada: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Canada: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Canada: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Austria Figure 1: Chile: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Chile: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Chile: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Chile: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Chile: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Chile: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 China Figure 1: China: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: China: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: China: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: China: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: China: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: China: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Columbia Figure 1: Columbia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Columbia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Columbia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Columbia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Columbia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Columbia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Croatia Figure 1: Croatia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Croatia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Croatia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Croatia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Croatia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Croatia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Czech Republic Figure 1: Czech Republic: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Czech Republic: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Czech Republic: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Czech Republic: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Czech Republic: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Czech Republic: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Denmark Figure 1: Denmark: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Denmark: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Denmark: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Denmark: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Denmark: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Denmark: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Dominican Republic Figure 1: Dominican Republic: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Dominican Republic: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Dominican Republic: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Dominican Republic: Pharmaceutical Market - Sales Share of Key Players (in %), 2011
IMARC
Figure 5: Dominican Republic: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Dominican Republic: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Ecuador Figure 1: Ecuador: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Ecuador: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Ecuador: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Ecuador: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Ecuador: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Ecuador: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Egypt Figure 1: Egypt: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Egypt: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Egypt: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Egypt: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Egypt: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Egypt: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Estonia Figure 1: Estonia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Estonia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Estonia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Estonia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Estonia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Estonia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Finland Figure 1: Finland: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Finland: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Finland: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Finland: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Finland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Finland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 France Figure 1: France: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: France: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: France: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: France: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: France: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: France: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Germany Figure 1: Germany: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Germany: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Germany: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Germany: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Germany: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Germany: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Global Figure 1: Global: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Global: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Global: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Global: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Global: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Global: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Greece Figure 1: Greece: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Greece: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Greece: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Greece: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Greece: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Greece: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Hong Kong Figure 1: Hong Kong : Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Hong Kong: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Hong Kong: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011
IMARC
Figure 4: Hong Kong: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Hong Kong: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Hong Kong: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Hungary Figure 1: Hungary: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Hungary: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Hungary: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Hungary: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Hungary: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Hungary: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 India Figure 1: India: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: India: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: India: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: India: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: India: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: India: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Indonesia Figure 1: Indonesia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Indonesia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Indonesia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Indonesia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Indonesia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Indonesia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Ireland Figure 1: Ireland: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Ireland: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Ireland: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Ireland: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Ireland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Ireland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Italy Figure 1: Italy: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Italy: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Italy: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Italy: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Italy: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Italy: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Japan Figure 1: Japan: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Japan: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Japan: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Japan: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Japan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Japan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Jordan Figure 1: Jordan: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Jordan: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Jordan: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Jordan: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Jordan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Jordan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Kuwait Figure 1: Kuwait: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Kuwait: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Kuwait: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Kuwait: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Kuwait: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Kuwait: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Latvia Figure 1: Latvia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Latvia: Pharmaceutical Market Forecast (in Million US$), 2012-2017
IMARC
Figure 3: Latvia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Latvia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Latvia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Latvia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Lebanon Figure 1: Lebanon: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Lebanon: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Lebanon: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Lebanon: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Lebanon: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Lebanon: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Lithuania Figure 1: Lithuania: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Lithuania: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Lithuania: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Lithuania: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Lithuania: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Lithuania: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Luxembourg Figure 1: Luxembourg: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Luxembourg: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Luxembourg: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Luxembourg: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Luxembourg: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Luxembourg: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Malaysia Figure 1: Malaysia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Malaysia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Malaysia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Malaysia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Malaysia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Malaysia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Mexico Figure 1: Mexico: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Mexico: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Mexico: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Mexico: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Mexico: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Mexico: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Morocco Figure 1: Morocco: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Morocco: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Morocco: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Morocco: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Morocco: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Morocco: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Netherland Figure 1: Netherland: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Netherland: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Netherland: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Netherland: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Netherland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Netherland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 New Zealand Figure 1: New Zealand: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: New Zealand: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: New Zealand: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: New Zealand: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: New Zealand: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: New Zealand: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Norway Figure 1: Norway: Pharmaceutical Market (in Million US$), 2007-2011
IMARC
Figure 2: Norway: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Norway: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Norway: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Norway: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Norway: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Pakistan Figure 1: Pakistan: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Pakistan: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Pakistan: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Pakistan: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Pakistan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Pakistan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Peru Figure 1: Peru: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Peru: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Peru: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Peru: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Peru: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Peru: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Philippines Figure 1: Philippines: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Philippines: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Philippines: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Philippines: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Philippines: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Philippines: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Poland Figure 1: Poland: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Poland: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Poland: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Poland: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Poland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Poland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Portugal Figure 1: Portugal: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Portugal: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Portugal: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Portugal: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Portugal: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Portugal: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Puerto Rico Figure 1: Puerto Rico: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Puerto Rico: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Puerto Rico: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Puerto Rico: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Puerto Rico: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Puerto Rico: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Romania Figure 1: Romania: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Romania: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Romania: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Romania: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Romania: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Romania: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Russia Figure 1: Russia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Russia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Russia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Russia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Russia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Russia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Saudi Arab
IMARC
Figure 1: Saudi Arab: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Saudi Arab: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Saudi Arab: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Saudi Arab: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Saudi Arab: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Saudi Arab: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Singapore Figure 1: Singapore: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Singapore: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Singapore: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Singapore: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Singapore: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Singapore: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Slovakia Figure 1: Slovakia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Slovakia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Slovakia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Slovakia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Slovakia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Slovakia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Slovenia Figure 1: Slovenia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Slovenia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Slovenia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Slovenia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Slovenia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Slovenia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 South Africa Figure 1: South Africa: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: South Africa: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: South Africa: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: South Africa: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: South Africa: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: South Africa: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 South Korea Figure 1: South Korea: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: South Korea: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: South Korea: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: South Korea: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: South Korea: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: South Korea: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Spain Figure 1: Spain: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Spain: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Spain: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Spain: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Spain: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Spain: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Sweden Figure 1: Sweden: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Sweden: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Sweden: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Sweden: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Sweden: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Sweden: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Switzerland Figure 1: Switzerland: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Switzerland: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Switzerland: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Switzerland: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Switzerland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Switzerland: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011
IMARC
Taiwan Figure 1: Taiwan: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Taiwan: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Taiwan: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Taiwan: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Taiwan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Taiwan: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Thailand Figure 1: Thailand: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Thailand: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Thailand: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Thailand: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Thailand: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Thailand: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Tunisia Figure 1: Tunisia: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Tunisia: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Tunisia: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Tunisia: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Tunisia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Tunisia: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Turkey Figure 1: Turkey: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Turkey: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Turkey: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Turkey: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Turkey: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Turkey: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 United Arab Emirates Figure 1: United Arab Emirates: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: United Arab Emirates: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: United Arab Emirates: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: United Arab Emirates: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: United Arab Emirates: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: United Arab Emirates: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 United Kingdom Figure 1: United Kingdom: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: United Kingdom: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: United Kingdom: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: United Kingdom: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: United Kingdom: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: United Kingdom: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011 Uruguay Figure 1: Uruguay: Pharmaceutical Market (in Million US$), 2007-2011 Figure 2: Uruguay: Pharmaceutical Market Forecast (in Million US$), 2012-2017 Figure 3: Uruguay: Pharmaceutical Market - Sales Share of Key Players (in %), 2007-2011 Figure 4: Uruguay: Pharmaceutical Market - Sales Share of Key Players (in %), 2011 Figure 5: Uruguay: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2007-2011 Figure 6: Uruguay: Pharmaceutical Market - Sales Share of Key Therapeutic Areas (in %), 2011
IMARC
Analysis by Region Global Figure 1: Global: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: Global: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: Global: Pharmaceutical Market - Sales Share by Region (in %), 2017 North America Figure 1: North America: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: North America: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: North America: Pharmaceutical Market - Sales Share by Region (in %), 2017 Asia Pacific Figure 1: Asia Pacific: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: Asia Pacific: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: Asia Pacific: Pharmaceutical Market - Sales Share by Region (in %), 2017 Europe Figure 1: Europe: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: Europe: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: Europe: Pharmaceutical Market - Sales Share by Region (in %), 2017 Latin America & Caribbean Figure 1: Latin America & Caribbean: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: Latin America & Caribbean: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: Latin America & Caribbean: Pharmaceutical Market - Sales Share by Region (in %), 2017 Middle East & Africa Figure 1: Middle East & Africa: Pharmaceutical Market - Sales by Region (in Million US$), 2007-2017 Figure 2: Middle East & Africa: Pharmaceutical Market - Sales Share by Region (in %), 2011 Figure 3: Middle East & Africa: Pharmaceutical Market - Sales Share by Region (in %), 2017
IMARC
Total Market Performance Sheet
This sheet allows you to:
Analyze the historical pharmaceutical market sales for each country during 2007 - 2011
Analyze the historical pharmaceutical market growth rates for each country during 2007 - 2011
Analyze the projected pharmaceutical market sales for each country during 2012 - 2017
Analyze the projected pharmaceutical market growth rates for each country during 2012 – 2017
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America &
Caribbean and Middle East & Africa
Data is hidden as this is a
sample screen shot
Data is hidden as this is a
sample screen shot
Data is hidden as this is a sample screen shot
IMARC
Countries Covered in Each Region:
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands,
Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania,
Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand,
Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and
Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico,
Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab
Emirates, Lebanon, Tunisia, Jordan and Kuwait
Total Regions Covered: 6 Total Countries Covered: 70
IMARC
Performance of Key Players
This sheet allows you to:
Analyze the sales of key pharmaceutical manufacturers in each country during 2007 - 2011
Analyze the market shares of key pharmaceutical manufacturers in each country during 2007 - 2011
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America &
Caribbean and Middle East & Africa
Countries Covered in Each Region:
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands,
Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania,
Data is hidden as this
is a sample screen
shot
Data is hidden as
this is a sample
screen shot
Data is hidden as this is a sample screen shot Data is hidden as this is a sample screen shot
IMARC
Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand,
Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and
Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico,
Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab
Emirates, Lebanon, Tunisia, Jordan and Kuwait
Total Regions Covered: 6 Total Countries Covered: 70
IMARC
Performance By Therapeutic Area
This sheet allows you to:
Analyze the sales of key therapeutic classes in each country during 2007 - 2011
Analyze the sales shares of key therapeutic classes in each country during 2007 -2011
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America &
Caribbean and Middle East & Africa
Countries Covered in Each Region:
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands,
Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania,
Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Data is hidden as this is
a sample screen shot
Data is hidden as this is
a sample screen shot
Data is hidden as this is a sample screen shot Data is hidden as this is a sample screen shot
IMARC
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand,
Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and
Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico,
Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab
Emirates, Lebanon, Tunisia, Jordan and Kuwait
Total Regions Covered: 6 Total Countries Covered: 70
IMARC
Sales Performance by Region
This sheet allows you to:
Analyze the historical sales breakup of each region by country during 2007 - 2011
Analyze the projected sales breakup of each region by country during 2012 - 2017
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America &
Caribbean and Middle East & Africa
Countries Covered in Each Region:
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands,
Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania,
Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Data is hidden as this is a sample screen shot
Data is hidden as this is a sample screen shot
IMARC
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand,
Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and
Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico,
Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab
Emirates, Lebanon, Tunisia, Jordan and Kuwait
Total Regions Covered: 6 Total Countries Covered: 70
IMARC
Share Performance by Region
This sheet allows you to:
Analyze the historical sales share breakup of each region by country during 2007-2011
Analyze the projected sales share breakup of each region by country during 2012-2017
Regions Covered: Global, North America, Europe, Asia Pacific, Latin America &
Caribbean and Middle East & Africa
Countries Covered in Each Region:
North America: United States and Canada
Europe: Germany, France, Italy, Spain, United Kingdom, Russia, Turkey, Netherlands,
Poland, Greece, Belgium, Switzerland, Austria, Sweden, Portugal, Hungary, Romania,
Denmark, Czech Republic, Finland, Ireland, Norway, Slovakia, Bulgaria, Croatia,
Slovenia, Lithuania, Latvia, Luxembourg and Estonia
Data is hidden as this is a sample screen shot
Data is hidden as this is a sample screen shot
IMARC
Asia Pacific: Japan, China, South Korea, Australia, India, Taiwan, Indonesia, Thailand,
Philippines, Pakistan, Vietnam, Bangladesh, Hong Kong, New Zealand, Malaysia and
Singapore
Latin America & Caribbean: Brazil, Mexico, Venezuela, Argentina, Puerto Rico,
Colombia, Chile, Ecuador, Peru, Dominican Republic and Uruguay
Middle East & Africa: South Africa, Egypt, Saudi Arab, Algeria, Morocco, United Arab
Emirates, Lebanon, Tunisia, Jordan and Kuwait
Total Regions Covered: 6 Total Countries Covered: 70
IMARC
About IMARC
For more than 5 years, the International Market Analysis Research and Consulting Group has
been a leading advisor on management strategy and market research worldwide. We partner
with clients in all sectors and regions to identify their highest-value opportunities, address their
most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological
developments for business leaders in pharmaceutical, industrial, and high technology
organizations. Market forecasts and industry analysis for biotechnology, advanced materials,
pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing
methods are at the top of the company's expertise.
IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and
markets with close cooperation at all levels of the client organization. This ensures that our
clients achieve unmatchable competitive advantage, build more proficient organizations, and
secure lasting results.